Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
8.14
-0.06 (-0.73%)
At close: Aug 15, 2025, 3:59 PM
7.91
-2.83%
After-hours: Aug 15, 2025, 04:00 PM EDT
-0.73% (1D)
Bid | 7.71 |
Market Cap | 385.04M |
Revenue (ttm) | -11.61M |
Net Income (ttm) | -68.13M |
EPS (ttm) | -1.67 |
PE Ratio (ttm) | -4.87 |
Forward PE | 738 |
Analyst | Buy |
Ask | 8.4 |
Volume | 9,781 |
Avg. Volume (20D) | 7,514 |
Open | 8.20 |
Previous Close | 8.20 |
Day's Range | 7.87 - 8.23 |
52-Week Range | 2.76 - 8.47 |
Beta | 1.50 |
About NBTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+18.51%
Nanbotix shares are trading higher after the compa...
Unlock content with
Pro Subscription
6 months ago
+7.26%
Nanobiotix shares are trading higher after the company announced it began its Phase 2 trial for an innovative cancer treatment in stage 3 lung cancer.